Canadian Pharmacy Blog

Several new drugs are showing great promise in treating kidney cancer, a dif-ficult-to-treat form of cancer. The drugs are “targeted” to attack certain molecular mechanisms that spur cancer growth. The disease is usually resistant to chemotherapy. Only one drug has been approved for kidney cancer, interleukin-2 (IL-2). IL-2 can bring about complete remissions in 3% [...]

The Food and Drug Administration (FDA) has approved temsirolimus (Torisel, Wyeth) for the treatment of advanced kidney cancer. In a clinical trial of 626 patients, one group received the study drug alone, another received a comparator agent (interferon alfa), and the third group received a combination of the two. The temsirolimus-alone group showed a significant [...]